2 documents found, page 1 of 1

Sort by Issue Date

The 2-hydroxy-nevirapine metabolite as a candidate for boosting apolipoprotein ...

Marinho, Aline T.; Batuca, Joana R.; Miranda, Joana P.; Caixas, Umbelina; Dias, Clara G.; Branco, Teresa; Soto, Karina; Pinheiro, Pedro

The antiretroviral nevirapine (NVP) is associated to a reduction of atherosclerotic lesions and increases in high-density lipoprotein (HDL)-cholesterol. Despite being a hepatotoxic drug, which forbids its re-purposing to other therapeutic areas, not all NVP metabolites have the same potential to induce toxicity. Our aim was to investigate the effects of NVP and its metabolites in an exploratory study, towards t...


Medicines for the Treatment Of COVID-19: Awaiting the Evidence

Marto, Natalia; Monteiro, Emília C.

The novel severe acute respiratory syndrome coronavirus 2 is the cause of Coronavirus Disease 2019, a new illness with no effective treatment or vaccine that has reached pandemic proportions. In this document, we analyze how health authorities and agencies around the world position themselves regarding the off-label use of repurposed drugs or new investigational drugs to treat Coronavirus Disease 2019. We revie...

Date: 2020   |   Origin: Acta Médica Portuguesa

2 Results

Queried text

Refine Results

Author















Date



Document Type


Funding



Access rights



Resource



Subject